难治性-话题@MedSci

#难治性#

683篇内容 | 2650人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1528883, encodeId=a944152888311, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Headache Pain：单脉冲经颅磁刺激可有效预防性治疗难治性偏头痛, objectType=article, longId=730236, objectId=b3eee302362f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3eee302362f, replyNumber=0, likeNumber=101, createdTime=2022-06-24, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3eee302362f, moduleTitle=J Headache Pain：单脉冲经颅磁刺激可有效预防性治疗难治性偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3eee302362f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528880, encodeId=9b1315288807d, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, objectType=article, longId=730182, objectId=b81ce30182de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b81ce30182de, replyNumber=0, likeNumber=117, createdTime=2022-06-23, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b81ce30182de, moduleTitle=Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b81ce30182de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528879, encodeId=ed6815288e923, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, objectType=article, longId=729557, objectId=269be2955716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=269be2955716, replyNumber=0, likeNumber=93, createdTime=2022-06-16, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=269be2955716, moduleTitle=Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=269be2955716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528878, encodeId=7fb115288e882, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Neurology：药物难治性癫痫患者脑电评估后预后的预测因素, objectType=article, longId=729285, objectId=0db4e2928533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0db4e2928533, replyNumber=0, likeNumber=78, createdTime=2022-06-15, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0db4e2928533, moduleTitle=Neurology：药物难治性癫痫患者脑电评估后预后的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0db4e2928533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528877, encodeId=47bb15288e758, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Headache Pain：单脉冲经颅磁刺激预防性治疗难治性偏头痛, objectType=article, longId=729156, objectId=609fe2915636, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=609fe2915636, replyNumber=0, likeNumber=73, createdTime=2022-06-13, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=609fe2915636, moduleTitle=J Headache Pain：单脉冲经颅磁刺激预防性治疗难治性偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=609fe2915636)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528876, encodeId=7a8e15288e61c, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Clin Oncol：采用KTE-X19治疗复发/难治性套细胞淋巴瘤的3年随访结果, objectType=article, longId=728874, objectId=d52ae288743f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d52ae288743f, replyNumber=0, likeNumber=78, createdTime=2022-06-09, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d52ae288743f, moduleTitle=J Clin Oncol：采用KTE-X19治疗复发/难治性套细胞淋巴瘤的3年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d52ae288743f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528875, encodeId=ec4915288e5ed, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, objectType=article, longId=728872, objectId=66cae28872f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=66cae28872f3, replyNumber=0, likeNumber=77, createdTime=2022-06-09, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=66cae28872f3, moduleTitle=J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66cae28872f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528874, encodeId=e8d715288e417, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, objectType=article, longId=728635, objectId=9e8ce2863581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8ce2863581, replyNumber=0, likeNumber=102, createdTime=2022-06-06, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8ce2863581, moduleTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8ce2863581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528873, encodeId=4b2115288e3d4, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2022 ASCO：复发或难治性B细胞非霍奇金淋巴瘤中CD20和CD19表达缺失，一项回顾性队列研究, objectType=article, longId=728566, objectId=eb89e28566e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb89e28566e7, replyNumber=0, likeNumber=122, createdTime=2022-06-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb89e28566e7, moduleTitle=2022 ASCO：复发或难治性B细胞非霍奇金淋巴瘤中CD20和CD19表达缺失，一项回顾性队列研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb89e28566e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528872, encodeId=5cd815288e211, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, objectType=article, longId=728521, objectId=9843e28521fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9843e28521fc, replyNumber=0, likeNumber=79, createdTime=2022-06-04, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9843e28521fc, moduleTitle=2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9843e28521fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528871, encodeId=ab3115288e1f5, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Nature：开发出治疗难治性肿瘤的新方法, objectType=article, longId=728333, objectId=7a6be28333c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7a6be28333c5, replyNumber=0, likeNumber=78, createdTime=2022-06-02, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7a6be28333c5, moduleTitle=Nature：开发出治疗难治性肿瘤的新方法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7a6be28333c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528870, encodeId=4b8115288e0f0, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, objectType=article, longId=728258, objectId=3b8ae28258e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b8ae28258e7, replyNumber=0, likeNumber=78, createdTime=2022-06-01, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b8ae28258e7, moduleTitle=2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b8ae28258e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528869, encodeId=8410152886952, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=OCC 2022 | 基层难治性高血压患者管理, objectType=article, longId=727956, objectId=32b3e2795646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32b3e2795646, replyNumber=0, likeNumber=0, createdTime=2022-05-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32b3e2795646, moduleTitle=OCC 2022 | 基层难治性高血压患者管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32b3e2795646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528868, encodeId=499515288687b, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤, objectType=article, longId=727301, objectId=6669e2730156, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6669e2730156, replyNumber=0, likeNumber=68, createdTime=2022-05-20, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6669e2730156, moduleTitle=Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6669e2730156)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528866, encodeId=045815288661e, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR, objectType=article, longId=726862, objectId=923fe2686288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=923fe2686288, replyNumber=0, likeNumber=101, createdTime=2022-05-16, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923fe2686288, moduleTitle=通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=923fe2686288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528867, encodeId=128c152886eef, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, objectType=article, longId=726769, objectId=f014e26769c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f014e26769c3, replyNumber=0, likeNumber=73, createdTime=2022-05-14, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f014e26769c3, moduleTitle=AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f014e26769c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528865, encodeId=4b7c1528865ec, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=Diabetologia:成人1型糖尿病和难治性低血糖的特征, objectType=article, longId=726191, objectId=f5b0e26191d8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5b0e26191d8, replyNumber=0, likeNumber=87, createdTime=2022-05-07, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5b0e26191d8, moduleTitle=Diabetologia:成人1型糖尿病和难治性低血糖的特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5b0e26191d8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528863, encodeId=fb45152886312, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=JAMA Cardiol：经皮心间隔射频消融术可有效治疗难治性肥厚型梗阻性心肌病, objectType=article, longId=725663, objectId=c4dee2566385, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4dee2566385, replyNumber=0, likeNumber=73, createdTime=2022-04-29, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4dee2566385, moduleTitle=JAMA Cardiol：经皮心间隔射频消融术可有效治疗难治性肥厚型梗阻性心肌病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4dee2566385)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528862, encodeId=1339152886292, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, objectType=article, longId=725533, objectId=55e3e255332a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55e3e255332a, replyNumber=0, likeNumber=0, createdTime=2022-04-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e3e255332a, moduleTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e3e255332a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1528861, encodeId=26ed1528861cc, content=<a href='/topic/show?id=74b798601a1' target=_blank style='color:#2F92EE;'>#难治性#</a>, objectTitle=通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR, objectType=article, longId=725531, objectId=3a03e2553107, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a03e2553107, replyNumber=0, likeNumber=91, createdTime=2022-04-28, rootId=0, userName=freve, userId=a1ef11916292, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a03e2553107, moduleTitle=通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a03e2553107)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

难治性

2020-05-29

freve (审核中...)

前往app查看评论内容

#难治性#

J Headache Pain：单脉冲经颅磁刺激可有效预防性治疗难治性偏头痛

2022-06-24

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet：Liso-cel vs 标准疗法二线治疗原发难治性/早期复发性大B细胞淋巴瘤

2022-06-23

freve (审核中...)

前往app查看评论内容

#难治性#

Ann Oncol：Pimitespib可显著改善TKI难治性晚期胃肠道间质瘤的预后

2022-06-16

freve (审核中...)

前往app查看评论内容

#难治性#

Neurology：药物难治性癫痫患者脑电评估后预后的预测因素

2022-06-15

freve (审核中...)

前往app查看评论内容

#难治性#

J Headache Pain：单脉冲经颅磁刺激预防性治疗难治性偏头痛

2022-06-13

freve (审核中...)

前往app查看评论内容

#难治性#

J Clin Oncol：采用KTE-X19治疗复发/难治性套细胞淋巴瘤的3年随访结果

2022-06-09

freve (审核中...)

前往app查看评论内容

#难治性#

J Clin Oncol：Ciltacabtagene autoleucel治疗复发/难治性多发性骨髓瘤的长期预后

2022-06-09

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶

2022-06-06

freve (审核中...)

前往app查看评论内容

#难治性#

2022 ASCO：复发或难治性B细胞非霍奇金淋巴瘤中CD20和CD19表达缺失，一项回顾性队列研究

2022-06-04

freve (审核中...)

前往app查看评论内容

#难治性#

2022 ASCO：戈利昔替尼用于治疗难治性或复发性外周T细胞淋巴瘤的I期/II期研究

2022-06-04

freve (审核中...)

前往app查看评论内容

#难治性#

Nature：开发出治疗难治性肿瘤的新方法

2022-06-02

freve (审核中...)

前往app查看评论内容

#难治性#

2022 ASCO：对复发性或难治性广泛期小细胞肺癌患者连续服用他拉唑帕尼（TALA）加间歇性低剂量替莫唑胺（TMZ）的2期研究

2022-06-01

freve (审核中...)

前往app查看评论内容

#难治性#

OCC 2022 | 基层难治性高血压患者管理

2022-05-28

freve (审核中...)

前往app查看评论内容

#难治性#

Lancet Oncol：采用EZH2抑制剂Tzemetostat治疗复发/难治性恶性胸膜间皮瘤

2022-05-20

freve (审核中...)

前往app查看评论内容

#难治性#

通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR

2022-05-16

freve (审核中...)

前往app查看评论内容

#难治性#

AJH：针对 B 细胞成熟抗原的 CAR-T 细胞疗法对复发/难治性多发性骨髓瘤有效，包括体能状态不佳的病例

2022-05-14

freve (审核中...)

前往app查看评论内容

#难治性#

Diabetologia:成人1型糖尿病和难治性低血糖的特征

2022-05-07

freve (审核中...)

前往app查看评论内容

#难治性#

JAMA Cardiol：经皮心间隔射频消融术可有效治疗难治性肥厚型梗阻性心肌病

2022-04-29

freve (审核中...)

前往app查看评论内容

#难治性#

通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR

2022-04-28

freve (审核中...)

前往app查看评论内容

#难治性#

通用型CAR-NK用于复发/难治性急性髓系白血病（AML），3/5例获得CR

2022-04-28

科室
- - 订阅+
  - 更多科室
工具
服务